BTI
IDYA icon

Blue Trust Inc’s IDEAYA Biosciences IDYA Stock Holding History

Blue Trust Inc’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19K Hold
32
– – ﹤0.01% 2266
2026
Q1 		$1.07K Hold
32
– – ﹤0.01% 2249
2025
Q4 		$1.11K Hold
32
– – ﹤0.01% 2269
2025
Q3 		$871 Hold
32
– – ﹤0.01% 2352
2025
Q2 		$673 Buy
+32
New +$614 ﹤0.01% 2293

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Blue Trust Inc's IDYA Position: Q2 2026 in Review

Blue Trust Inc held its IDEAYA Biosciences (IDYA) position steady in Q2 2026 at 32 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2266.

Blue Trust Inc first reported a position in IDYA in Q2 2025 and has held it in 5 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Blue Trust Inc held 32 shares of IDEAYA Biosciences worth $1.19K as of Q2 2026.
  • Blue Trust Inc left its IDEAYA Biosciences share count unchanged in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2266 holding.
  • Blue Trust Inc first reported a position in IDEAYA Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.